Adjuvant treatment for early ovarian cancer: a randomized phase III trial of intraperitoneal 32P or intravenous cyclophosphamide and cisplatin - a Gynecologic Oncology Group study

Author： Naumann R. Wendel  

Publisher： Informa Healthcare

ISSN： 1473-3404

Source： The Women's Oncology Review, Vol.4, Iss.1, 2004-01, pp. : 33-34

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Phase I Study of Intraperitoneal Interferon-α2b and Intravenous cis-Platinum plus Cyclophosphamide Chemotherapy in Patients with Untreated Stage III Epithelial Ovarian Cancer: A Gynecologic Oncology Group Pilot Study

By Moore D.H.   Valea F.   Walton L.A.   Soper J.   Clarke-Pearson D.   Fowler Jr. W.C.  

Gynecologic Oncology, Vol. 59, Iss. 2, 1995-11 ,pp. : 267-272

Academic Press

Access to resources Recommend Favorite

A Phase II Study of Intraperitoneal Cisplatin and Thiotepa in Residual Ovarian Carcinoma: A Gynecologic Oncology Group Study

By Feun L.G.   Blessing J.A.   Major F.J.   DiSaia P.J.   Alvarez R.D.   Berek J.S.  

Gynecologic Oncology, Vol. 71, Iss. 3, 1998-12 ,pp. : 410-415

Elsevier

Access to resources Recommend Favorite

Intraperitoneal -Interferon Alternating with Cisplatin in Residual Ovarian Carcinoma: A Phase II Gynecologic Oncology Group Study

By Berek J.S.   Markman M.   Blessing J.A.   Kucera P.R.   Nelson B.E.   Anderson B.   Hanjani P.  

Gynecologic Oncology, Vol. 74, Iss. 1, 1999-07 ,pp. : 48-52

Elsevier

Access to resources Recommend Favorite

Intraperitoneal versus Intravenous Cisplatin in Combination with Intravenous Cyclophosphamide and Epidoxorubicin in Optimally Cytoreduced Advanced Epithelial Ovarian Cancer: A Randomized Trial of the Gruppo Oncologico Nord-Ovest

By Gadducci A.   Carnino F.   Chiara S.   Brunetti I.   Tanganelli L.   Romanini A.   Bruzzone M.   Conte P.F.   GONO Collaborative Centers  

Gynecologic Oncology, Vol. 76, Iss. 2, 2000-02 ,pp. : 157-162

Elsevier

Access to resources Recommend Favorite

Phase II Trial of Intraperitoneal Cisplatin with Intravenous Doxorubicin and Cyclophosphamide in Previously Untreated Patients with Advanced Ovarian Cancer-Long-Term Follow-Up

By Morgan R.J.   Braly P.   Cecchi G.   Leong L.   Shibata S.   Margolin K.   Somlo G.   McNamara M.   Longmate J.   Schinke S.   Raschko J.   Nagasawa S.   Kogut N.   Parker P.   Stein A.   Cho J.   Smith E.   Coluzzi P.   Najera L.   Johnson D.   Womack E.   Doroshow J.H.  

Gynecologic Oncology, Vol. 75, Iss. 3, 1999-12 ,pp. : 419-426

Elsevier

Access to resources Recommend Favorite